Genenta Science SPA
NASDAQ:GNTA

Watchlist Manager
Genenta Science SPA Logo
Genenta Science SPA
NASDAQ:GNTA
Watchlist
Price: 5.01 USD -6.53% Market Closed
Market Cap: 91.6m USD
Have any thoughts about
Genenta Science SPA?
Write Note

Genenta Science SPA
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genenta Science SPA
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Genenta Science SPA
NASDAQ:GNTA
Total Receivables
€2m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Philogen SpA
MIL:PHIL
Total Receivables
€11.4m
CAGR 3-Years
31%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Ulisse Biomed Spa
MIL:UBM
Total Receivables
€960.8k
CAGR 3-Years
7%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Genenta Science SPA
Glance View

Market Cap
91.6m USD
Industry
Biotechnology

Genenta Science SpA engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. The company is headquartered in Milan, Milano and currently employs 4 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.

GNTA Intrinsic Value
1.07 USD
Overvaluation 79%
Intrinsic Value
Price

See Also

What is Genenta Science SPA's Total Receivables?
Total Receivables
2m EUR

Based on the financial report for Dec 31, 2023, Genenta Science SPA's Total Receivables amounts to 2m EUR.

What is Genenta Science SPA's Total Receivables growth rate?
Total Receivables CAGR 3Y
39%

Over the last year, the Total Receivables growth was 27%. The average annual Total Receivables growth rates for Genenta Science SPA have been 39% over the past three years .

Back to Top